Company profile: AMSBIO
1.1 - Company Overview
Company description
- Provider of life science technology products and services for R&D in medical, nutrition, cosmetics, and energy, including monoclonal, polyclonal, and secondary antibodies; GMP compliance support; FDA-aligned tissue arrays for immunohistochemistry; protein expression; transduction-ready lentivirus, adenovirus, and AAV; and peptide and antibody production services.
Products and services
- Lentivirus & Adenovirus & AAV: AMSBIO supplies transduction-ready lentivirus, adenovirus, and AAV particles for gene delivery across research applications
- Antibodies: AMSBIO delivers research-grade monoclonal, polyclonal, and secondary antibodies for various research and diagnostic applications
- FDA Tissue Arrays: AMSBIO engineers FDA-aligned tissue arrays designed in alignment with FDA standards for immunohistochemistry
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AMSBIO
ABclonal
HQ: China
Website
- Description: Provider of global antibody and molecular enzyme reagents, offering antibodies for research and diagnostic applications; proteins, peptides, ELISA kits to detect and quantify proteins and other molecules; molecular biology reagents; and next-generation sequencing products and services for genetic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ABclonal company profile →
Halo Labs
HQ: United States
Website
- Description: Provider of biopharmaceutical quality control tools and particle analysis systems using optics, image processing, and microfluidics. Offerings include Aura+ analyzers; Aura PTx for protein therapy stability; Aura GT for viral vector stability; Aura CL for cell therapy particle characterization; Particle Vue software (21 CFR Part 11); and 0.8 µm black membrane plates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Halo Labs company profile →
JEOL
HQ: United States
Website
- Description: Provider of SEM and TEM (including cryo-EM) for high-resolution imaging and analysis, mass spectrometers for protein characterization, pharmaceuticals and high-throughput screening, NMR spectrometers for molecular structure analysis, EPMA for elemental analysis and high spatial resolution imaging, and FIB systems for sample preparation, imaging and analysis; based in Peabody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JEOL company profile →
ChromoTek
HQ: Germany
Website
- Description: Provider of immunologic research and detection reagents and tools for proteomics and cell biology, offering Nanobody-based Nano-Traps for immunoprecipitation; Chromobodies for real-time, live-cell imaging; Nano-Secondary reagents for higher-resolution imaging with minimal label displacement; Nano-Boosters & Nano-Labels for microscopy; Nano-Caps for one-step protein purification; and Nano-CaptureLigands for site-directed antibody immobilization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChromoTek company profile →
Algonomics
HQ: Belgium
Website
- Description: Provider of structural bioinformatics services to develop rationally designed therapeutics in immunotherapy, leveraging a proprietary platform for structure-based protein and peptide design. Belgium-based biotech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Algonomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AMSBIO
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AMSBIO
2.2 - Growth funds investing in similar companies to AMSBIO
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AMSBIO
4.2 - Public trading comparable groups for AMSBIO
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →